These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 24983206)

  • 1. Resource use in patients hospitalized with complicated skin and soft tissue infections in Europe and analysis of vulnerable groups: the REACH study.
    Ostermann H; Blasi F; Medina J; Pascual E; McBride K; Garau J;
    J Med Econ; 2014 Oct; 17(10):719-29. PubMed ID: 24983206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current management of patients hospitalized with complicated skin and soft tissue infections across Europe (2010-2011): assessment of clinical practice patterns and real-life effectiveness of antibiotics from the REACH study.
    Garau J; Ostermann H; Medina J; Avila M; McBride K; Blasi F;
    Clin Microbiol Infect; 2013 Sep; 19(9):E377-85. PubMed ID: 23663184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-European early switch/early discharge opportunities exist for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections.
    Nathwani D; Eckmann C; Lawson W; Stephens JM; Macahilig C; Solem CT; Simoneau D; Chambers R; Li JZ; Haider S
    Clin Microbiol Infect; 2014 Oct; 20(10):993-1000. PubMed ID: 24673973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic treatment patterns across Europe in patients with complicated skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus: a plea for implementation of early switch and early discharge criteria.
    Eckmann C; Lawson W; Nathwani D; Solem CT; Stephens JM; Macahilig C; Simoneau D; Hajek P; Charbonneau C; Chambers R; Li JZ; Haider S
    Int J Antimicrob Agents; 2014 Jul; 44(1):56-64. PubMed ID: 24928311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic outcomes of inappropriate initial antibiotic treatment for complicated skin and soft tissue infections: a multicenter prospective observational study.
    Lipsky BA; Napolitano LM; Moran GJ; Vo L; Nicholson S; Chen S; Boulanger L; Kim M
    Diagn Microbiol Infect Dis; 2014 Jun; 79(2):266-72. PubMed ID: 24657171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and Outcomes of Complicated Skin and Soft Tissue Infections among Inpatients in Southern China from 2008 to 2013.
    Li X; Chen Y; Gao W; Ouyang W; Wei J; Wen Z
    PLoS One; 2016; 11(2):e0149960. PubMed ID: 26918456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of vancomycin and linezolid in patients with peripheral vascular disease and/or diabetes in an observational European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.
    Eckmann C; Nathwani D; Lawson W; Corman S; Solem C; Stephens J; Macahilig C; Li J; Charbonneau C; Baillon-Plot N; Haider S
    Clin Microbiol Infect; 2015 Sep; 21 Suppl 2():S33-9. PubMed ID: 26198370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the economic value of avoiding hospital admissions by shifting the management of gram+ acute bacterial skin and skin-structure infections to an outpatient care setting.
    Ektare V; Khachatryan A; Xue M; Dunne M; Johnson K; Stephens J
    J Med Econ; 2015; 18(12):1092-101. PubMed ID: 26368787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of costs and hospital length of stay associated with intravenous/oral linezolid or intravenous vancomycin treatment of complicated skin and soft-tissue infections caused by suspected or confirmed methicillin-resistant Staphylococcus aureus in elderly US patients.
    McCollum M; Sorensen SV; Liu LZ
    Clin Ther; 2007 Mar; 29(3):469-77. PubMed ID: 17577468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid.
    Bassetti M; Baguneid M; Bouza E; Dryden M; Nathwani D; Wilcox M
    Clin Microbiol Infect; 2014 Apr; 20 Suppl 4():3-18. PubMed ID: 24580738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of real-world characteristics on outcomes for patients with methicillin-resistant Staphylococcal skin and soft tissue infections: a multi-country medical chart review in Europe.
    Nathwani D; Eckmann C; Lawson W; Solem CT; Corman S; Stephens JM; Macahilig C; Simoneau D; Chambers R; Li JZ; Haider S
    BMC Infect Dis; 2014 Sep; 14():476. PubMed ID: 25182029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight-based antibiotic dosing in a real-world European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.
    Lawson W; Nathwani D; Eckmann C; Corman S; Stephens J; Solem C; Macahilig C; Li J; Baillon-Plot N; Charbonneau C; Haider S
    Clin Microbiol Infect; 2015 Sep; 21 Suppl 2():S40-6. PubMed ID: 26206621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes and management costs in patients hospitalized for skin and skin-structure infections.
    Itani KM; Merchant S; Lin SJ; Akhras K; Alandete JC; Hatoum HT
    Am J Infect Control; 2011 Feb; 39(1):42-9. PubMed ID: 20673598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early response to antibiotic treatment in European patients hospitalized with complicated skin and soft tissue infections: analysis of the REACH study.
    Garau J; Blasi F; Medina J; McBride K; Ostermann H;
    BMC Infect Dis; 2015 Feb; 15():78. PubMed ID: 25879713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early switch/early discharge opportunities for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections in Brazil.
    Furtado GH; Rocha J; Hayden R; Solem C; Macahilig C; Tang WY; Chambers R; Figueiredo MLN; Johnson C; Stephens J; Haider S
    Braz J Infect Dis; 2019; 23(2):86-94. PubMed ID: 31078574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of tigecycline for the treatment of complicated skin and soft-tissue infections in real-life clinical practice from five European observational studies.
    Montravers P; Bassetti M; Dupont H; Eckmann C; Heizmann WR; Guirao X; García MS; Capparella MR; Simoneau D; Bodmann KF
    J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii15-24. PubMed ID: 23772042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
    Stein GE; Wells EM
    Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance mechanisms and epidemiology of multiresistant pathogens in Europe and efficacy of tigecycline in observational studies.
    Heizmann WR; Dupont H; Montravers P; Guirao X; Eckmann C; Bassetti M; García MS; Capparella MR; Simoneau D; Bodmann KF
    J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii45-55. PubMed ID: 23772046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of empiric antimicrobial treatments for skin and soft tissue infections in newly hospitalized patients.
    Yazdani C; Hanna N
    J Pharm Pract; 2014 Feb; 27(1):53-60. PubMed ID: 24076599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospitalizations with healthcare-associated complicated skin and skin structure infections: impact of inappropriate empiric therapy on outcomes.
    Zilberberg MD; Shorr AF; Micek ST; Chen J; Ramsey AM; Hoban AP; Pham V; Doherty JA; Mody SH; Kollef MH
    J Hosp Med; 2010; 5(9):535-40. PubMed ID: 20734456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.